Will accelerated Laser PCR benefit time critical molecular tests?




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Will accelerated Laser PCR benefit time critical molecular tests?
Released on: March 15, 2017. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Revolutionising the fundamentals of scientific and medical research.
  • Summary
  • Transcript
  • Participants
  • Company
Revolutionising the fundamentals of scientific and medical research. GNA Biosolutions is a Munich-based High-tech engineering firm which has developed instruments, OEM modules, and assays for ultra-fast, molecular pathogen detection - thanks to its proprietary, breakthrough technology. Federico Bürsgens the Managing Director of GNA Biosolutions discusses the story behind GNS Biosolutions with Adrian Dawkes of PharmaVentures.
Revolutionising the fundamentals of scientific and medical research. GNA Biosolutions is a Munich-based High-tech engineering firm which has developed instruments, OEM modules, and assays for ultra-fast, molecular pathogen detection - thanks to its proprietary, breakthrough technology. Federico Bürsgens the Managing Director of GNA Biosolutions discusses the story behind GNS Biosolutions with Adrian Dawkes of PharmaVentures.
Federico is one of the three founders of GNA Biosolutions GmbH. He holds the post of Managing Director with the primary responsibilities for GNA’s finances as well technology-wise for the optoelectronic and software development. Federico has started his entrepreneurial career in high-school and thus gained many years of business planning experience. Federico began his undergraduate studies of physics at the University of Münster/Germany, and then enrolled at the Universities of Würzburg/Germany and the University of Texas at Austin, where he earned his Master’s degree in physics in 2003. During his entire studies Federico was a fellow of the German National Academic Foundation (Studienstiftung). Afterwards, Federico moved to Munich/Germany where he worked in the Center for nanoscience and obtained his PhD in physics from Ludwig-Maximilians-Universität in 2008. He is author and co-author of 16 peer-reviewed scientific papers on detection technology.
GNA’s breakthrough technology Laser PCR® with local heating GNA employ a radically new approach to PCR, with heating and cooling rates that are many orders of magnitude faster than any PCR so far. This is achieved by adding laser heated nanoparticles to the solution, which function as the world’s smallest thermal cyclers. This local heating technology drives GNA’s new PCR amplification (Laser PCR®) and fluorescent-free DNA detection (NANOSTOVE®).